Healthcare Realty Trust Inc
F:HT0

Watchlist Manager
Healthcare Realty Trust Inc Logo
Healthcare Realty Trust Inc
F:HT0
Watchlist
Price: 17.3 EUR 0.58% Market Closed
Market Cap: €6.6B

Healthcare Realty Trust Inc
Investor Relations

Healthcare Realty Trust owns and manages medical office buildings and other outpatient properties, mostly on or near hospital campuses. It rents space to doctors, physician groups, hospitals, and health systems that need convenient places for patient visits, diagnostic services, and administrative work. In simple terms, it is a landlord for healthcare real estate. The company makes money mainly from long-term lease income. Tenants pay base rent, and in many cases also help cover property expenses such as maintenance, taxes, and utilities. Because its buildings are tied to the everyday needs of healthcare providers, the business depends less on retail-style foot traffic and more on the stable demand for medical services. What makes its model different is its close link to the healthcare delivery system. Medical office properties are built around how doctors and hospitals serve patients, so location and tenant relationships matter a lot. Healthcare Realty Trust sits between capital and care delivery: it owns the buildings, provides the space, and collects recurring rent from healthcare users who need dependable, long-term locations.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 1, 2026
AI Summary
Q1 2026

Strong quarter: Healthcare Realty said first-quarter results were far better than expected, with normalized FFO per share of $0.41 and same-store cash NOI growth of 6.9%.

Leasing momentum: The company signed more than 2 million square feet of leases, an all-time high, while same-store occupancy rose to 92.3% and total occupancy reached 90.5%.

Guidance raised: Management lifted full-year normalized FFO per share guidance to $1.59 to $1.65 and raised same-store cash NOI growth guidance to 3.75% to 4.75%.

Capital allocation: The company bought back $100 million of stock in the quarter, completed a joint venture acquisition, and continued redevelopments, while keeping leverage targeted in the mid-5x area.

Growth focus: Management argued the old “steady growth” medical office model is no longer enough and said the company is targeting materially higher organic earnings growth, with 2026 core earnings growth tracking above 5% before certain portfolio and deleveraging impacts.

Key Financials
Normalized FFO per share
$0.41
Same-store cash NOI growth
6.9%
FAD per share
$0.32
Quarterly dividend payout ratio
75%
Same-store occupancy
92.3%
Total occupancy
90.5%
Tenant retention
93.5%
Cash leasing spread
4.2%
Leases signed
more than 2 million square feet
Annual escalators
3.1%
Weighted average lease term
nearly 8 years
Revised FFO guidance midpoint
$1.62
Revised same-store cash NOI guidance midpoint
4.25%
Stock repurchases
$100 million
Remaining buyback capacity
$400 million
Acquisitions
more than $20 million
Redevelopment investment
$25 million
Redevelopment portfolio
23 properties
Redevelopment pre-leased
64%
Redevelopment upside
$50 million of NOI upside
Joint venture share of NOI
5%
New term loan
$400 million
Bond maturity
$600 million
Commercial paper outstanding
roughly $250 million
Swap rate locked
SOFR at 3.3%
New yield assumption
greater than 7%
Year-end leverage target
mid-5x area
SNO pipeline
490,000 square feet
New leasing pipeline
approximately 1.4 million square feet
Core earnings growth
above 5%
Earnings Call Recording
Other Earnings Calls

Management

Ms. Constance B. Moore
Interim President, CEO & Director
No Bio Available
Mr. Robert E. Hull
Executive VP & COO
No Bio Available
Ms. Julie F. Wilson
Executive VP & Chief Administrative Officer
No Bio Available
Mr. John M. Bryant Jr.
Executive VP & General Counsel
No Bio Available
Mr. Austen Helfrich
Interim Chief Financial Officer
No Bio Available
Ms. Amanda L. Callaway
Senior VP & Chief Accounting Officer
No Bio Available
Mr. Andy Baxter
VP & CTO
No Bio Available
Mr. Ronald M. Hubbard
Vice President of Investor Relations
No Bio Available
Ms. Bethany A. Mancini
Associate Vice President of Corporate Communications
No Bio Available
Ms. Revell M. Michael
Vice President of Marketing
No Bio Available

Contacts

Address
TENNESSEE
Nashville
3310 W End Ave
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett